Evaluating the cost-benefit profile of CPI stem cell therapy demands a comprehensive perspective. Supporters often emphasize the potential for significant therapeutic gains, principally in diseases where conventional therapies have proven ineffective. However, it's to evaluate the considerable financial expenditure associated with CPI stem cell the